肿瘤坏死因子相关凋亡诱导配体（Tumor Related Apoptosis Inducing Ligand，TRAIL）是肿瘤坏死因子家族成员之一，于1995年由Wiley等发现，是一种II型跨膜蛋白。
基于4个网页-相关网页
Tumor Necrosis Factor-related Apoptosis-inducing Ligand 凋亡诱导配体 ; 亡诱导配体 ; 研究肿瘤坏死因子相关凋亡诱导配体 ; 相关的凋亡诱导配体
Aim: to investigate the relationship between the expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), cell proliferation and apoptosis in children's skin hemangioma.
目的探讨小儿皮肤血管瘤各阶段肿瘤坏死因子相关凋亡诱导配体(TRAIL)的表达与细胞增殖和凋亡的关系。
Objective to investigate the correlation between sensitivity to tumor necrosis factor-related apoptosis inducing ligand (TRAIL) and expression level of death receptor 5 (DR5) on tumor cell surface.
目的探讨肿瘤细胞表面dr5表达水平与其对肿瘤坏死因子相关的凋亡诱导配体(TRAIL)敏感性之间的关系。
Objective: To explore the role of tumor necrosis factor-related apoptosis-inducing ligand(TRAIL) combined with chemotherapeutic agents in treating neuroblastoma(NB) and the possible mechanism.
目的：探讨肿瘤坏死因子相关凋亡诱导配体（TRAIL）联合化疗药物治疗神经母细胞瘤（NB）的作用及其可能机制。
应用推荐